Dr. Ann-Kathrin Bernert is Head of Production. She is responsible for ATMP production, driving GMP process development, and the advancement of innovative cell and gene therapies. She brings more than eight years of experience in the development of CAR T and CAR NK cell therapies and holds a PhD focused on the GMP compliant manufacturing of CAR NK cell therapies.